Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.

Autor: Gnant M; Medical University of Vienna, Comprehensive Cancer Center, Vienna.; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Frantal S; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Pfeiler G; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna., Steger GG; Department of Internal Medicine I, Medical University of Vienna, Vienna., Egle D; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Greil R; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria., Fitzal F; Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna., Wette V; Breast Center Carinthia, St. Veit, Austria., Balic M; Division of Oncology, Department of Internal Medicine, and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria., Haslbauer F; Department of Internal Medicine, Salzkammergut Klinikum Hospital Vöcklabruck, Vöcklabruck, Austria., Melbinger-Zeinitzer E; Department of Surgery, Hospital Wolfsberg, Wolfsberg, Austria., Bjelic-Radisic V; Department of Gynecology and Obstetrics, Medical University of Graz, Graz, Austria.; Breast Unit, Helios University Hospital Wuppertal, Wuppertal Germany, University Witten/Herdecke, Germany., Artner-Matuschek S; Department of Gynecology, Hanusch Hospital Vienna, Vienna., Kainberger F; Division of Neuro- and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna., Ritter M; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Rinnerthaler G; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria., Sevelda P; Department of Gynecology, Karl Landsteiner Institute for Gynecologic Oncology and Senology, Hospital Hietzing, Vienna., Bergh J; Department of Oncology-Pathology, Cancer Research Karolinska Institutet, Stockholm., Kacerovsky-Strobl S; Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna.; Breast Health Center, St. Francis Hospital Vienna, Vienna., Suppan C; Division of Oncology, Department of Internal Medicine, and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria., Brunner C; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Deutschmann C; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna., Gampenrieder SP; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria., Fohler H; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Jakesz R; Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna., Fesl C; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Singer C; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna.

Publikováno v: NEJM evidence [NEJM Evid] 2022 Dec; Vol. 1 (12), pp. EVIDoa2200162. Date of Electronic Publication: 2022 Nov 18.